Appendix 2A - Application for quotation of securities Announcement Summary Entity name TELIX PHARMACEUTICALS LIMITED Announcement Type New announcement Date of this announcement Wednesday October 28, 2026 The +securities to be quoted are: Other Please refer to the response to Q2.3d for further...
Application for quotation of securities - TLX
Filed with ASX · · 6 pages · English
Watch Telix Pharmaceuticals' latest callTelix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call · Replay · Aug 20Read the transcript of Telix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings CallRelease
Telix Pharmaceuticals Limited on 6ix
Earlier from Telix Pharmaceuticals
- Appendix 3Y Dr Christian Behrenbruch
- Appendix 3Y William Jellison
- Appendix 3Y Change in Director Interest - D Gill
- Telix Reports Third Quarter 2026 Financial Performance
- Telix Highlights Pivotal Trials in Prostate, Brain and Renal Cancers and Next Generation Theranostics at EANM
Later from Telix Pharmaceuticals
- Telix Notice of General Meeting, Proxy Form and Online Guide
- Notice of General Meeting
- Cancellation of Appendix 2A
- Notification regarding unquoted securities - TLX
- Change of Director's Interest Notice - Marie McDonald
Follow Telix Pharmaceuticals into a list and get an email when it puts out news.
Follow Telix Pharmaceuticals